Resistance history does not affect response to dolutegravir / lamivudine
Adherence counselling reverses viral rebound on dolutegravir in 95% of cases
Switches away from integrase inhibitors do not reverse weight gain, studies find
NRTI-sparing regimen effective for children and adolescents
Dolutegravir alone maintains HIV suppression in those treated early
Same-day viral load test installed in Uganda, but people with HIV still received results months later
Real-world data confirm the efficacy of dolutegravir-based dual therapy
Top 5 HIV treatment stories from CROI 2023
Top 5 stories on HIV in Africa from CROI 2023
